Cleared Traditional

K200160 - 740 SafeSAT

K200160 is an FDA 510(k) clearance for 740 SafeSAT, manufactured by Zoe Medical, Inc.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 390-day FDA review.

K200160 · Zoe Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2021
Decision
390d
Days
Class 2
Risk

K200160 is an FDA 510(k) clearance for the 740 SafeSAT. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Zoe Medical, Inc. (Topsfield, US). The FDA issued a Cleared decision on February 15, 2021 after a review of 390 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Zoe Medical, Inc. devices

FDA 510(k) Submission Details - K200160

510(k) Number K200160 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 22, 2020
Decision Date February 15, 2021
Days to Decision 390 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
265d slower than avg
Panel avg: 125d · This submission: 390d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 151
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K200160.
Philips MR Patient Care Portal
K212227 · Invivo Corporation · Sep 2021
Vitals360 Multi-Vitals Mobile Monitor
K210086 · Vocare, Inc. · May 2021
ZOLL Propaq M
K202375 · ZOLL Medical Corporation · Mar 2021
MouthLab Vital Signs Monitoring System
K201635 · Multisensor Diagnostics (Dba Aidar Health) · Feb 2021
Vital Signs Monitor:iM3s, iM3As, iM3Bs, iHM3s
K202892 · Edan Instruments, Inc. · Jan 2021
T3 Platform software
K202306 · Etiometry, Inc. · Nov 2020